1. Home
  2. WST vs CHT Comparison

WST vs CHT Comparison

Compare WST & CHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CHT
  • Stock Information
  • Founded
  • WST 1923
  • CHT 1996
  • Country
  • WST United States
  • CHT Taiwan
  • Employees
  • WST N/A
  • CHT N/A
  • Industry
  • WST Medical/Dental Instruments
  • CHT Telecommunications Equipment
  • Sector
  • WST Health Care
  • CHT Telecommunications
  • Exchange
  • WST Nasdaq
  • CHT Nasdaq
  • Market Cap
  • WST 15.6B
  • CHT 34.2B
  • IPO Year
  • WST N/A
  • CHT 2003
  • Fundamental
  • Price
  • WST $227.12
  • CHT $44.51
  • Analyst Decision
  • WST Buy
  • CHT
  • Analyst Count
  • WST 7
  • CHT 0
  • Target Price
  • WST $331.67
  • CHT N/A
  • AVG Volume (30 Days)
  • WST 646.1K
  • CHT 143.4K
  • Earning Date
  • WST 07-24-2025
  • CHT 08-05-2025
  • Dividend Yield
  • WST 0.37%
  • CHT 2.92%
  • EPS Growth
  • WST N/A
  • CHT 2.51
  • EPS
  • WST 6.37
  • CHT 0.15
  • Revenue
  • WST $2,895,800,000.00
  • CHT $6,937,345,324.00
  • Revenue This Year
  • WST $3.38
  • CHT $4.00
  • Revenue Next Year
  • WST $5.85
  • CHT $1.19
  • P/E Ratio
  • WST $35.63
  • CHT $30.63
  • Revenue Growth
  • WST N/A
  • CHT 3.08
  • 52 Week Low
  • WST $187.43
  • CHT $36.11
  • 52 Week High
  • WST $352.33
  • CHT $47.03
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • CHT 44.84
  • Support Level
  • WST $219.60
  • CHT $43.74
  • Resistance Level
  • WST $233.84
  • CHT $46.95
  • Average True Range (ATR)
  • WST 5.29
  • CHT 0.46
  • MACD
  • WST 0.60
  • CHT -0.37
  • Stochastic Oscillator
  • WST 66.82
  • CHT 23.40

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CHT Chunghwa Telecom Co. Ltd.

Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.

Share on Social Networks: